<DOC>
	<DOCNO>NCT01299376</DOCNO>
	<brief_summary>This study two part . In first part , efficacy safety MK-0954E ( losartan potassium 50 mg [ L50 ] ( + ) hydrochlorothiazide 12.5 mg [ H12.5 ] ( + ) amlodipine besylate 5mg [ A5 ] ) evaluate compare efficacy safety MK-0954H ( L50/H12.5 ) Japanese participant . In second part , safety tolerability long-term use open-label MK-0954E participant hypertension evaluate . The primary hypothesis MK-0954E effective lower mean trough sit diastolic blood pressure ( SiDBP ) 8 week treatment compare MK-954H ( L50/H12.5 mg ) Japanese participant essential hypertension adequately control follow 8-week treatment filter period study drug MK-954H .</brief_summary>
	<brief_title>MK-0954E Phase III Long-Term Study Participants With Hypertension ( MK-0954E-356 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion criterion : Participant diagnosis essential hypertension Participant treat single , dual combination treatment hypertension able discontinue prior antihypertensive medication Participant mean trough SiDBP ≥ 90 mmHg &lt; 110 mmHg Participant mean trough SiSBP ≥ 140 mmHg &lt; 200 mmHg Participant clinically significant abnormality screen visit Exclusion criterion : Participant currently take &gt; 2 antihypertensive medication Participant history significant multiple and/or severe allergy ingredient NuLotan Preminent , amlodipine dihydropyridine drug thiazide drug relate drug ( i.e. , sulfonamidecontaining `` chlortalidone '' medicine ) Participant , time signing informed consent , user recreational illicit drug recent history within last year drug alcohol abuse dependence Participant pregnant breastfeeding , expect conceive OR pregnancy test positive screening visit ( Visit 1 ) Participant currently participate participate study investigational compound device within 30 day sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Antihypertensive agent</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Uncontrolled hypertension</keyword>
</DOC>